CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 278

Industry reads hand-picked by our editors

Sep 28, 2017

Science
France brings back a phased-out drug after patients rebel against its replacement
Vox
We have a cure for hepatitis C. But the neediest can’t afford it. Louisiana wants to change that.
Sports Illustrated
At the Andrews Institute, stem cells are seen as the next stage in sports medicine

Sep 27, 2017

The New York Times
Can heart disease shed light on cancer?
Kaiser Health News
Right after Trump blamed high drug prices on campaign cash, drugmakers gave more
Mother Jones
Dogs can be vaccinated against Lyme disease. Humans can’t.

Sep 26, 2017

Bloomberg
Cheap drugs pay for Aurobindo as U.S. FDA approvals surge
Boston Business Journal
Cambridge cancer drug startup eyes $40M IPO eight months after launch
Forbes
Physician (and pharma, and insurance executive) pay: Doing too well by doing good

Sep 25, 2017

Bloomberg
Pfizer spins off new company to develop some rare disease drugs
Politico
Congressional aides risk conflicts with stock trades
USA Today
Hurricane Maria halts crucial drug manufacturing in Puerto Rico, may spur shortages

Sep 22, 2017

Reuters
Many drug companies fail to conduct timely safety checks on medicines after FDA approval
Kaiser Health News
High on drugs? Anthem cites soaring drug costs to justify 35% rate hike in California
MIT Technology Review
The easiest place to use CRISPR might be in your ear

Sep 21, 2017

Bloomberg
Cheer Alnylam's drug, pause on its platform
USA Today
CVS to limit opioid drug prescriptions amid national epidemic
Reuters
Africa to get state-of-art HIV drugs for $75 a year

Sep 20, 2017

Financial Times
Andrew Witty jumps into biotech venture capital sector
Phys.org
Technique could make it easier to use mRNA to treat disease or deliver vaccines
McClatchy DC
Attorneys general investigate role pharma companies played in opioid crisis

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Infographic
Pharma's Resource Challenge: Doing More With Less Custom content for Woven Health Collective
Playbook
Nuclear Medicine Logistics: Precision Delivery Solutions Custom content for Marken
Podcast
Amyloids and Beyond Custom content for Pearson

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Peptides Under Pressure: Analytical Challenges in a High-Stakes Market Webinar - on demand • Provided by Solvias
Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.